Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study-Reference-Cited by-同舟云学术

Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study

Published:2014-06 Issue:3 Volume:104 Page:459-466
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Mühlenbruch Kristin,Ludwig Tonia,Jeppesen Charlotte,Joost Hans-Georg,Rathmann Wolfgang,Meisinger Christine,Peters Annette,Boeing Heiner,Thorand Barbara,Schulze Matthias B.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference37 articles.

1. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes;Buijsse;Epidemiol Rev,2011

2. Risk models and scores for type 2 diabetes: systematic review;Noble;BMJ,2011

3. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes;Schulze;Diabetes Care,2007

4. Diabetes family history: a metabolic storm you should not sit out;Franks;Diabetes,2010

5. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition;Boeing;Ann Nutr Metab,1999

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intersectional analysis of social disparities in type 2 diabetes risk among adults in Germany: results from a nationwide population-based survey;BMC Public Health;2024-02-16

2. Chronic disease outcome metadata from German observational studies – public availability and FAIR principles;Scientific Data;2023-12-05

3. Intersectional analysis of social disparities in type 2 diabetes risk among adults in Germany: results from a nationwide population-based survey;2023-10-24

4. Der Deutsche Diabetes Risiko Test;Diabetes aktuell;2023-06

5. German diabetes risk score for the determination of the individual type 2 diabetes risk—10-year prediction and external validations;Deutsches Ärzteblatt international;2022-09-30